Arog Pharmaceuticals is a clinical stage biotechnology company developing targeted small molecules therapies for the treatment of cancer.
AROG Pharmaceuticals, LLC.
Management
Technology
Deals/Partnering
Research Pipeline
Funding
BioStartup's Score
0 / 50
KEY DETAILS
Websitehttps://www.arogpharmaceuticals.com
Founded2010
Disease Focus
Development Stage
STOCK CODENon Listed
Address5420 LBJ Freeway, Suite 410, TX 75240DallasUnited States
5420 LBJ Freeway, Suite 410, TX 75240
Dallas
United States
Contact Number
[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/arog-pharmaceuticals-llc” connections=”true” suffix=””]
In May 2010, AROG entered into an exclusive agreement with Pfizer Inc., to acquire the worldwide development rights to Plarotinib/ARO-002/CP-868-596. Plarotinib was originally developed by Pfizer in partnership with OSI Pharmaceuticals Inc.